110 related articles for article (PubMed ID: 32798403)
1. [Expression of Versican and Its Related Molecules in Patient with Multiple Myeloma and Its Clinical Significance].
Wu YQ; Luo LY; Tang YN; Li HJ; Li YJ; Wang Y; Yao Y; Li DP; Xu KL; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1228-1233. PubMed ID: 32798403
[TBL] [Abstract][Full Text] [Related]
2. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
Gupta N; Khan R; Kumar R; Kumar L; Sharma A
Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
[TBL] [Abstract][Full Text] [Related]
3. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
Gupta N; Kumar R; Seth T; Garg B; Sharma A
RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
Gupta N; Kumar R; Sharma A
Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and potential pathogenesis of VCAN in adult non-cystic fibrosis bronchiectasis: a retrospective study.
Huang WY; Hong KK; He RQ; Luo J; Huang ZG; Zhang CY; Xu Y; Bao CX; Zhang LM; Chen G; Kong JL
BMC Pulm Med; 2024 Apr; 24(1):209. PubMed ID: 38685004
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Blimp-1 mRNA in Bone Marrow Mononuclear Cells in Multiple Myeloma Patients and Its Clinical Significance].
Hu WT; Liu JW; Liu HC; Wang TT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1443-1448. PubMed ID: 27784372
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Ghosh S; Albitar L; LeBaron R; Welch WR; Samimi G; Birrer MJ; Berkowitz RS; Mok SC
Gynecol Oncol; 2010 Oct; 119(1):114-20. PubMed ID: 20619446
[TBL] [Abstract][Full Text] [Related]
10. [Significance of Bone Marrow Microvessel Density and Vascular- Related Factors in Multiple Myeloma].
Xie YB; Fang LF; Jiang BL; Han GX; Shen K; Li WQ; Chen SB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1179-1184. PubMed ID: 31418376
[TBL] [Abstract][Full Text] [Related]
11. Versican A-subdomain is required for its adequate function in dermal development.
Hatano S; Nagai N; Sugiura N; Tsuchimoto J; Isogai Z; Kimata K; Ota A; Karnan S; Hosokawa Y; Watanabe H
Connect Tissue Res; 2018 Mar; 59(2):178-190. PubMed ID: 28488903
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer.
Zhai L; Chen W; Cui B; Yu B; Wang Y; Liu H
Tissue Cell; 2021 Dec; 73():101611. PubMed ID: 34358918
[TBL] [Abstract][Full Text] [Related]
13. [Short-Term Therapeutic Efficacy, Survival Time and Side Effects in Treatment of Newly Diagnosed Multiple Myeloma Patients with Different Chemotherapeutic Regimens].
Pan PJ; Luo ZQ; Zhang ML
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):855-859. PubMed ID: 31204944
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma.
Zhang Q; Wu J; Chen X; Zhao M; Zhang D; Gao F
Biomed Res Int; 2021; 2021():6949864. PubMed ID: 33604385
[TBL] [Abstract][Full Text] [Related]
15. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
[TBL] [Abstract][Full Text] [Related]
16. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced expression of Vcan mRNA splice form proteins alters heart morphology and cellular protein profiles.
Burns TA; Dours-Zimmermann MT; Zimmermann DR; Krug EL; Comte-Walters S; Reyes L; Davis MA; Schey KL; Schwacke JH; Kern CB; Mjaatvedt CH
PLoS One; 2014; 9(2):e89133. PubMed ID: 24586547
[TBL] [Abstract][Full Text] [Related]
18. Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma.
Xu J; Zhao Y; Sun H; Xiao Q; Ye P
Int J Gen Med; 2021; 14():4639-4651. PubMed ID: 34434056
[TBL] [Abstract][Full Text] [Related]
19. The expression of versican and its role in pancreatic neuroendocrine tumors.
Gao H; Cheng Y; Chen Y; Luo F; Shao Y; Sun Z; Bai C
Pancreatology; 2020 Jan; 20(1):142-147. PubMed ID: 31771905
[TBL] [Abstract][Full Text] [Related]
20. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
